Alnylam Pharmaceuticals, Inc.
Alnylam Pharmaceuticals, Inc. (ALNY) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · ALNY · as of Jun 8, 2026
Key Statistics
Explore Alnylam Pharmaceuticals, Inc. Data
alny stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 52 · Buy rate: 75.0%
The ALNY analyst consensus is Buy, based on ratings from 52 Wall Street analysts over the past 3 months. The average 12-month price target is $445.67, representing +47.06% upside from the current price of $303.05.
Competitors & Peers
alny competitorsALNY
ARGX
BDX
CAH
CI
CORStock Performance
Full HistoryAbout Alnylam Pharmaceuticals, Inc.
Alnylam Pharmaceuticals, Inc. a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of…
what is alnylam pharmaceuticals, inc. · alny stock overview · alnylam pharmaceuticals, inc. company profile · who is alnylam pharmaceuticals, inc. ceo · alny NASDAQ · alnylam pharmaceuticals, inc. headquarters · alnylam pharmaceuticals, inc. business segments
About Stock Overview & Key Data
Alnylam Pharmaceuticals, Inc. (ALNY) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Jun 1, 2004. As of the latest trading session, ALNY stock price is $303.05, with a market capitalization of $40.5B. The stock has returned -0.31% over the past 12 months and -23.79% year-to-date.
According to 52 Wall Street analysts, the consensus rating for Alnylam Pharmaceuticals, Inc. stock is Buy, with an average 12-month price target of $445.67. In fiscal year 2025, Alnylam Pharmaceuticals, Inc. reported revenue of $3.7B and net income of $313.7M. For detailed data — including Alnylam Pharmaceuticals, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Alnylam Pharmaceuticals, Inc. (ALNY) stock price is $303.05. The stock is traded on NASDAQ under the ticker symbol ALNY. The 52-week range is $283.10 – $495.55.